2nd International Conference on Dementia and Alzheimer's Disease Dementia 2024
DATE : Mar 04-05, 2024
LOCATION :Barcelona, Spain
About our conference.
Welcome to the 2nd International Conference on Dementia and Alzheimer’s Disease!
We are delighted to invite you to join us for this prestigious 2nd International Conference on Dementia and Alzheimer’s Disease during March 04-05, 2024 at Barcelona, Spain, where leading experts, researchers, clinicians, and professionals from around the world will gather to discuss the latest advancements in the field of dementia and Alzheimer’s disease.
Dementia and Alzheimer’s disease pose significant challenges to individuals, families, and healthcare systems globally. This conference aims to foster knowledge exchange, collaboration, and innovative thinking to enhance our understanding of these neurodegenerative disorders. By bringing together esteemed professionals, we aim to accelerate scientific progress and explore effective strategies for prevention, diagnosis, and treatment.
Dementia 2024 will provide a platform for sharing groundbreaking research findings, clinical insights, and practical experiences. The event will feature keynote lectures, interactive workshops, panel discussions, and poster presentations, covering a wide range of topics such as neurobiology, genetics, imaging, cognitive assessment, therapeutic interventions, caregiving, and public health policies.
In addition to the scientific program, we have carefully curated networking opportunities that will allow you to connect with experts in the field, exchange ideas, and establish fruitful collaborations. Barcelona, known for its rich history, vibrant culture, and stunning architecture, serves as the perfect backdrop for this intellectually stimulating conference.
We encourage researchers, practitioners, educators, policymakers, and all those passionate about advancing the understanding and management of dementia and Alzheimer’s disease to join us at this exceptional event. Together, let’s strive towards improving the lives of individuals affected by these conditions and work towards a future where dementia is better understood, diagnosed, and treated.
We look forward to welcoming you to Barcelona for the Dementia Congress. Join us in this endeavor to make a meaningful impact on the lives of millions around the world.
Dementia 2024 – Conference Chair
Senior VP Google
VP & Managing Director
VP of Product
VP & Managing Director
Dementia and Alzheimer’s disease represent a significant global healthcare challenge, with an increasing prevalence and immense impact on individuals and society. According to the World Health Organization (WHO), approximately 50 million people worldwide are living with dementia, and this number is expected to triple by 2050.
In terms of economic impact, dementia and Alzheimer’s disease are estimated to cost the global economy over $1 trillion annually. This includes direct medical costs, long-term care expenses, and the indirect costs associated with caregiving and lost productivity.
The market for dementia and Alzheimer’s disease treatments and interventions has been growing steadily. In 2020, the global market for Alzheimer’s disease therapeutics was valued at $4.8 billion, and it is projected to reach $9.2 billion by 2026, with a compound annual growth rate (CAGR) of 10.6%.
The market is witnessing a shift towards personalized medicine and targeted therapies, as researchers focus on developing disease-modifying treatments. Innovative approaches, such as immunotherapies and precision medicine, offer promising prospects for slowing down disease progression and improving patient outcomes.
Additionally, there is an increasing emphasis on early diagnosis and intervention, leading to a growing demand for diagnostic tools and biomarkers. This has prompted investment in research and development efforts to identify reliable and accessible diagnostic methods for dementia and Alzheimer’s disease.
As the global population ages and the burden of dementia and Alzheimer’s disease continues to rise, there is a pressing need for effective treatments, improved diagnostics, and comprehensive care strategies. This creates a significant market opportunity for pharmaceutical companies, medical device manufacturers, and healthcare providers to address the unmet needs of individuals affected by these debilitating conditions.